Clinical Study to Evaluate the Safety and Efficacy of the Vela100

NCT01026441 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-05-05

No results posted yet for this study

Summary

This study is intended to test the safety of the Vela100 device when used for treatment for cellulite and circumference temporary reduction.

Conditions

  • Cellulite Reduction
  • Circumference Reduction

Interventions

DEVICE

Vela100 (Aesthetic)

6 treatments once a week

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026441 on ClinicalTrials.gov